Sowmya Sharma, MD
Assistant ProfessorCards
About
Research
Publications
2025
Characterizing Healthcare Disparities, Utilization, and Trends of Inflammatory Bowel Disease in Transgender and Nonbinary Patients: A Population-Based Study
Suchan A, Chaaban L, Kobeissi L, Hassan B, Liang F, Sharma S, Melia J. Characterizing Healthcare Disparities, Utilization, and Trends of Inflammatory Bowel Disease in Transgender and Nonbinary Patients: A Population-Based Study. Inflammatory Bowel Diseases 2025, 32: 643-649. PMID: 41400636, DOI: 10.1093/ibd/izaf266.Peer-Reviewed Original ResearchIncidence of Anti-Drug Antibody Development in Older Adults with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Inhibitors: A Large Multicenter Cohort Study
Frost S, Ambastha C, Patel D, Roney A, Greb A, Rangel-Garcia M, Sauk J, Chang C, Park S, Parian A, Suchan A, Moughames E, Krishna M, Chowdhury R, Sharma S, Maas L, Ho A, Lazarev M, Limketkai B, Limsui D, Keyashian K. Incidence of Anti-Drug Antibody Development in Older Adults with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Inhibitors: A Large Multicenter Cohort Study. Inflammatory Bowel Diseases 2025, 31: 3356-3362. PMID: 40971840, DOI: 10.1093/ibd/izaf170.Peer-Reviewed Original ResearchRetrospective Cohort Study on the Predictive Value of Primary Non-response to Initial Biologic for Future Biologic Use in Patients with Inflammatory Bowel Disease
Krishna M, Spartz E, Maas L, Cusumano V, Sharma S, Limketkai B, Parian A. Retrospective Cohort Study on the Predictive Value of Primary Non-response to Initial Biologic for Future Biologic Use in Patients with Inflammatory Bowel Disease. Digestive Diseases And Sciences 2025, 70: 746-753. PMID: 39755922, DOI: 10.1007/s10620-024-08816-9.Peer-Reviewed Original Research
2024
Primary healthcare provider-perceived barriers to implementing an evidence-based pathway for undifferentiated lower gastrointestinal tract symptoms: A qualitative inquiry
Sharma S, Stewart M, Mathias H, Novak K, Van Zanten S, Heisler C, Richard S, Neil E, Burge F, Smith A, Peltekian K, Patel S, Jones J. Primary healthcare provider-perceived barriers to implementing an evidence-based pathway for undifferentiated lower gastrointestinal tract symptoms: A qualitative inquiry. PLOS ONE 2024, 19: e0313201. PMID: 39739887, PMCID: PMC11687702, DOI: 10.1371/journal.pone.0313201.Peer-Reviewed Original Research
2023
PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease
Ismail M, Peters D, Rowe S, Salavati A, Sharma S, Anders R, Pomper M, Slusher B, Selaru F. PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease. Clinical And Experimental Gastroenterology 2023, 16: 237-247. PMID: 38090679, PMCID: PMC10714977, DOI: 10.2147/ceg.s404009.Peer-Reviewed Original ResearchTime for a Gut Check: A Qualitative Study of Proposed Interventions to Address Gender Inequality in Gastroenterology
Sharma S, Mathias H, Jones E, Heisler C, Rohatinsky N, Novak K, Leung Y, Fowler S, Kaczur M, Targownik L, Jones J. Time for a Gut Check: A Qualitative Study of Proposed Interventions to Address Gender Inequality in Gastroenterology. Journal Of The Canadian Association Of Gastroenterology 2023, 6: 155-161. PMID: 37811530, PMCID: PMC10558195, DOI: 10.1093/jcag/gwad022.Peer-Reviewed Original ResearchAntibody Kinetics after Three Doses of SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
Tsipotis E, Maremanda A, Zeiser L, Connolly C, Sharma S, Dudley-Brown S, Frey S, Lazarev M, Melia J, Parian A, Segev D, Truta B, Yu H, Werbel W, Selaru F. Antibody Kinetics after Three Doses of SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease. Medicina 2023, 59: 1487. PMID: 37629777, PMCID: PMC10456461, DOI: 10.3390/medicina59081487.Peer-Reviewed Original ResearchSuperior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn’s Perianal Fistulae
Maas L, Gao R, Cusumano V, Spartz E, Chowdhury R, Krishna M, Lazarev M, Melia J, Selaru F, Sharma S, Limketkai B, Parian A. Superior Efficacy of Infliximab Versus Adalimumab for First-Line Treatment of Crohn’s Perianal Fistulae. Digestive Diseases And Sciences 2023, 68: 3994-4000. PMID: 37540392, DOI: 10.1007/s10620-023-08060-7.Peer-Reviewed Original Research
2022
Perceived Barriers to Professional Equality Among Women in Gastroenterology
Jones E, Sharma S, Heisler C, Rohatinsky N, Novak K, Leung Y, Fowler S, Kaczur M, Jones J. Perceived Barriers to Professional Equality Among Women in Gastroenterology. Journal Of The Canadian Association Of Gastroenterology 2022, 5: 226-233. PMID: 36196275, PMCID: PMC9527661, DOI: 10.1093/jcag/gwac023.Peer-Reviewed Original Research
2021
Long-term outcomes of liver transplant recipients followed up in non-transplant centres: Care closer to home
Tsien C, Tan H, Sharma S, Palaniyappan N, Wijayasiri P, Leung K, Hayre J, Mowlem E, Kang R, Eddowes P, Wilkes E, Venkatachalapathy S, Guha I, Antonova L, Cheung A, Griffiths W, Butler A, Ryder S, James M, Aithal G, Aravinthan A. Long-term outcomes of liver transplant recipients followed up in non-transplant centres: Care closer to home. Clinical Medicine 2021, 21: e32-e38. PMID: 33479081, PMCID: PMC7850197, DOI: 10.7861/clinmed.2020-0609.Peer-Reviewed Original Research
Clinical Care
Overview
Clinical Specialties
Gastroenterology
Board Certifications
Gastroenterology
- Certification Organization
- Royal College of Physicians & Surgeons of CANADA
- Original Certification Date
- 2022
Internal Medicine
- Certification Organization
- Royal College of Physicians & Surgeons of CANADA
- Original Certification Date
- 2021
News
News
Get In Touch
Contacts
Academic Office Number
Clinic Fax Number
Appointment Number
Mailing Address
Yale School of Medicine
Department of Medicine (Digestive Diseases), PO Box 208019
New Haven, Connecticut 06520-8019
United States